Theranostics 2018; 8(2):328-340. doi:10.7150/thno.21917 This issue Cite

Research Paper

Development and Comparison of Two Immuno-disaggregation Based Bioassays for Cell Secretome Analysis

Pawan KC1, Fan Liu2, Jiang Zhe2✉, Ge Zhang1✉

1. Department of Biomedical Engineering, University of Akron, Akron, Ohio 44325, United States;
2. Department of Mechanical Engineering, University of Akron, Akron, Ohio 44325, United States.

Citation:
KC P, Liu F, Zhe J, Zhang G. Development and Comparison of Two Immuno-disaggregation Based Bioassays for Cell Secretome Analysis. Theranostics 2018; 8(2):328-340. doi:10.7150/thno.21917. https://www.thno.org/v08p0328.htm
Other styles

File import instruction

Abstract

Graphic abstract

Cell secretome analysis has gained increasing attention towards the development of effective strategies for disease treatment. Analysis of cell secretome enables the platform to monitor the status of disease progression, facilitating therapeutic outcomes. However, cell secretome analysis is very challenging due to its versatile and dynamic composition. Here, we report the development of two immuno-disaggregation bioassays using functionalized microparticles for the quantitative analysis of the cell secretome.

Methods: We evaluated the feasibility of our developed immuno-disaggregation bioassays using antibody-conjugated MPs and protein-conjugated MPs for the detection of target cell secretome protein. The vascular endothelial growth factor (VEGF)-165 protein was tested as a model cell secretome protein in the serum and serum-free conditions. The status of MP aggregates was examined with a light microscopy and AccuSizerTM 780 Optical Particle Sizer. The accuracy of our bioassays measurement was compared with standard ELISA method.

Results: The developed bioassays successfully detected target VEGF protein present in serum-free buffer and serum-containing complete cell culture medium with high sensitivity and specificity. Additionally, the immuno-disaggregation bioassays using antibody-conjugated MPs and protein-conjugated MPs have a wide detection range from 0.01 ng/mL to 100 ng/mL and 0.5 ng/mL to 100 ng/mL, respectively. The sensitivity of the bioassay using antibody-conjugated MPs was approximately one order of magnitude higher than the bioassay using protein-conjugated MPs.

Conclusion: Our promising results indicate the potential of the developed bioassays as powerful platforms for the quantitative analysis of cell secretome.

Keywords: Immuno-disaggregation, competitive immunoreaction, cell secretome, vascular endothelial growth factor, microparticle.


Citation styles

APA
KC, P., Liu, F., Zhe, J., Zhang, G. (2018). Development and Comparison of Two Immuno-disaggregation Based Bioassays for Cell Secretome Analysis. Theranostics, 8(2), 328-340. https://doi.org/10.7150/thno.21917.

ACS
KC, P.; Liu, F.; Zhe, J.; Zhang, G. Development and Comparison of Two Immuno-disaggregation Based Bioassays for Cell Secretome Analysis. Theranostics 2018, 8 (2), 328-340. DOI: 10.7150/thno.21917.

NLM
KC P, Liu F, Zhe J, Zhang G. Development and Comparison of Two Immuno-disaggregation Based Bioassays for Cell Secretome Analysis. Theranostics 2018; 8(2):328-340. doi:10.7150/thno.21917. https://www.thno.org/v08p0328.htm

CSE
KC P, Liu F, Zhe J, Zhang G. 2018. Development and Comparison of Two Immuno-disaggregation Based Bioassays for Cell Secretome Analysis. Theranostics. 8(2):328-340.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image